A resolution to recognize October 2024 as Uterine Fibroids Awareness Month.
By designating a month for awareness, the resolution intends to foster public understanding of uterine fibroids and the related health issues that disproportionately affect women of color, particularly Black women. The resolution discusses statistics that indicate that about 26 million women are affected by fibroids in the United States, a figure that may be underestimated due to a lack of awareness and diagnosis. The bill's recognition could lead to enhanced research and better care options for women battling this condition.
Senate Resolution 143 (SR0143) aims to recognize October 2024 as Uterine Fibroids Awareness Month. The resolution highlights the prevalence of uterine fibroids, which are non-cancerous growths that can cause significant health issues for many women, including pelvic pain, reproductive dysfunction, and infertility. The resolution seeks to acknowledge the serious impacts this condition has on women's lives while emphasizing the need for increased awareness and education regarding uterine fibroids.
While SR0143 serves as a call for increased awareness and research, it aligns with ongoing discussions and disparities facing women with uterine fibroids. The resolution suggests the necessity for improved detection and treatment protocols, acknowledging that many women remain undiagnosed or do not seek medical attention. There are concerns surrounding the implications of these disparities, with advocates urging legislative bodies to take further steps in promoting funding for research into uterine fibroids and improved medical responses to this prevalent issue.